Literature DB >> 10319157

Ricin A immunotoxins of IgG and Fab of anti-CALLA monoclonal antibody: effect of water soluble long-chain SPDP on conjugate yield, immunoselectivity and cytotoxicity.

B H Woo1, J T Lee, K C Lee.   

Abstract

The water soluble long-chain crosslinker, sulfo-succinimidyl-6-[3'-(2-pyridyldithio)-propionamido]hexanoate (S-LC-SPDP) was used to prepare ricin A chain (RTA) immunotoxins constructed with whole IgG and Fab fragments of the anti-common acute lymphoblastic leukemia antigen (CALLA) monoclonal antibody. In this study, a) S-LC-SPDP modification efficiencies of whole IgG and Fab, b) conjugation yields of the immunotoxins prepared and c) in vitro immunoreactivity and cytotoxicity of immunotoxins constructed were examined. IgG-RTA and Fab-RTA immunotoxins were prepared with 67.3% and 57.0% conjugation yields, respectively. These long spacer intermolecular linked immunotoxins were selectively immunoreactive and cytotoxic against to immunogenic Daudi cells but little or no-binding and cytotoxic against to antigen K562 cells. Both IgG-RTA and Fab-RTA immunotoxins were 210- and 45-fold more active than intact RTA in vitro, respectively.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 10319157     DOI: 10.1007/bf02979124

Source DB:  PubMed          Journal:  Arch Pharm Res        ISSN: 0253-6269            Impact factor:   4.946


  15 in total

Review 1.  Targeted kill: from umbrellas to monoclonal antibodies.

Authors:  V S Byers; R W Baldwin
Journal:  J Clin Immunol       Date:  1992-11       Impact factor: 8.317

Review 2.  Ribosome inactivating proteins of plants.

Authors:  J M Lord; M R Hartley; L M Roberts
Journal:  Semin Cell Biol       Date:  1991-02

3.  Effects of the intermolecular toxin-monoclonal antibody linkage on the in vivo stability, immunogenicity and anti-leukemic activity of B43 (anti-CD19) pokeweed antiviral protein immunotoxin.

Authors:  F M Uckun; D E Myers; J D Irvin; V M Kuebelbeck; D Finnegan; L M Chelstrom; L L Houston
Journal:  Leuk Lymphoma       Date:  1993-04

4.  Different biological properties of the two constituent peptide chains of ricin, a toxic protein inhibiting protein synthesis.

Authors:  S Olsnes; A Pihl
Journal:  Biochemistry       Date:  1973-07-31       Impact factor: 3.162

5.  Kinetics of protein synthesis inactivation by ricin-anti-Thy 1.1 monoclonal antibody hybrids. Role of the ricin B subunit demonstrated by reconstitution.

Authors:  R J Youle; D M Neville
Journal:  J Biol Chem       Date:  1982-02-25       Impact factor: 5.157

6.  Gelonin, a new inhibitor of protein synthesis, nontoxic to intact cells. Isolation, characterization, and preparation of cytotoxic complexes with concanavalin A.

Authors:  F Stirpe; S Olsnes; A Pihl
Journal:  J Biol Chem       Date:  1980-07-25       Impact factor: 5.157

7.  Comparison of the cytotoxic potency of T101 Fab, F(ab')2 and whole IgG immunotoxins.

Authors:  J M Derocq; P Casellas; G Laurent; S Ravel; H Vidal; F Jansen
Journal:  J Immunol       Date:  1988-10-15       Impact factor: 5.422

8.  Abrogation of the non-specific toxicity of abrin conjugated to anti-lymphocyte globulin.

Authors:  P E Thorpe; A J Cumber; N Williams; D C Edwards; W C Ross; A J Davies
Journal:  Clin Exp Immunol       Date:  1981-01       Impact factor: 4.330

9.  One-step purification of mouse monoclonal antibodies from ascites fluid by hydroxylapatite chromatography.

Authors:  L H Stanker; M Vanderlaan; H Juarez-Salinas
Journal:  J Immunol Methods       Date:  1985-01-21       Impact factor: 2.303

10.  Enhancement of toxicity of antitransferrin receptor antibody-Pseudomonas exotoxin conjugates by adenovirus.

Authors:  D J FitzGerald; I S Trowbridge; I Pastan; M C Willingham
Journal:  Proc Natl Acad Sci U S A       Date:  1983-07       Impact factor: 12.779

View more
  1 in total

Review 1.  Immunotoxins constructed with ribosome-inactivating proteins and their enhancers: a lethal cocktail with tumor specific efficacy.

Authors:  Roger Gilabert-Oriol; Alexander Weng; Benedicta von Mallinckrodt; Matthias F Melzig; Hendrik Fuchs; Mayank Thakur
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.